Skip to content

Clinical trials

Pancreatitis trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatitis Phase: Not applicable Country / region: China Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20113
20124
20133
20141
20162
20172
20202
20212
20223
20232
20243
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18
Completed8
Recruiting5
Not yet recruiting4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Air Force Military Medical University, China6
Ruijin Hospital6
Changhai Hospital5
Nanjing University School of Medicine2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
The First Affiliated Hospital of Nanchang University2
Almazov National Medical Research Centre1
Chinese University of Hong Kong1
First People's Hospital of Hangzhou1
Hepatopancreatobiliary Surgery Institute of Gansu Province1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatitis38
Pancreatitis, Acute Necrotizing5
Pancreatic Diseases2
Pancreatitis, Chronic2
Systemic Inflammatory Response Syndrome2
Abdominal Abscess1
Appendicitis1
Autoimmune Pancreatitis1
Cholangitis1
Cholelithiasis1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.